HRP20120168T1 - Postupak i međuprodukti kod dobivanja derivata n-(1-benzhidrilazetidin-3-il)-n-fenilmetilsulfonamida - Google Patents

Postupak i međuprodukti kod dobivanja derivata n-(1-benzhidrilazetidin-3-il)-n-fenilmetilsulfonamida Download PDF

Info

Publication number: HRP20120168T1
Authority: HR; Croatia
Prior art keywords: unbranched; carbon atoms; branched alkyl; formula; product
Prior art date: 2004-10-14

Application number

HR20120168T

Other languages

English (en)

Croatian (hr)

Inventor

Boffelli Philippe

Delthil Michel

Grondard Luc

Lampilas Maxime

Malpart Joel

Mutti St�Phane

Nait Bouda Lahlou

Rieke-Zapp Joerg

Original Assignee

Aventis Pharma S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-14

Filing date

2005-10-10

Publication date

2012-03-31

2005-10-10 Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.

2012-03-31 Publication of HRP20120168T1 publication Critical patent/HRP20120168T1/hr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Hematology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Anesthesiology (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HR20120168T 2004-10-14 2005-10-10 Postupak i međuprodukti kod dobivanja derivata n-(1-benzhidrilazetidin-3-il)-n-fenilmetilsulfonamida HRP20120168T1 (hr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0410845A FR2876689B1 (fr)	2004-10-14	2004-10-14	Nouveau procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide
PCT/FR2005/002489 WO2006040464A1 (fr)	2004-10-14	2005-10-10	Procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide

Publications (1)

Publication Number	Publication Date
HRP20120168T1 true HRP20120168T1 (hr)	2012-03-31

Family

ID=34953744

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20120168T HRP20120168T1 (hr)	2004-10-14	2005-10-10	Postupak i međuprodukti kod dobivanja derivata n-(1-benzhidrilazetidin-3-il)-n-fenilmetilsulfonamida

Country Status (32)

Country	Link
US (3)	US7429668B2 (de)
EP (1)	EP1802571B1 (de)
JP (1)	JP4971986B2 (de)
KR (1)	KR20070063540A (de)
CN (1)	CN101039903A (de)
AR (1)	AR051389A1 (de)
AT (1)	ATE534624T1 (de)
AU (1)	AU2005293453A1 (de)
BR (1)	BRPI0516526A (de)
CA (1)	CA2581781A1 (de)
CR (1)	CR9008A (de)
CY (1)	CY1112390T1 (de)
DK (1)	DK1802571T3 (de)
EA (2)	EA012523B1 (de)
ES (1)	ES2378181T3 (de)
FR (1)	FR2876689B1 (de)
HR (1)	HRP20120168T1 (de)
IL (1)	IL182277A0 (de)
MA (1)	MA29005B1 (de)
ME (1)	ME01297B (de)
MX (1)	MX2007004483A (de)
NO (1)	NO20072431L (de)
PL (1)	PL1802571T3 (de)
PT (1)	PT1802571E (de)
RS (1)	RS52132B (de)
SG (2)	SG144921A1 (de)
SI (1)	SI1802571T1 (de)
TN (1)	TNSN07115A1 (de)
TW (1)	TW200626542A (de)
UY (1)	UY29165A1 (de)
WO (1)	WO2006040464A1 (de)
ZA (1)	ZA200703011B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2925050B1 (fr) *	2007-12-14	2010-01-08	Sanofi Aventis	Nouveau procede de preparation de derives d'azetidine
HRP20130485T1 (en) *	2009-06-29	2013-06-30	Merz Pharma Gmbh & Co. Kgaa	Method of preparing 1-amino-1,3,3,5,5-pentamethylcyclohexane
HRP20130486T1 (en) *	2009-06-29	2013-06-30	Merz Pharma Gmbh & Co. Kgaa	Method of preparing neramexane
CN107089918B (zh) *	2017-04-08	2020-06-16	迪嘉药业集团有限公司	一种盐酸二苯甲胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9714129D0 (en) *	1997-07-04	1997-09-10	Pfizer Ltd	Azetidines
US6566356B2 (en) *	2000-03-03	2003-05-20	Aventis Pharma S.A.	Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
FR2805817B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
FR2814678B1 (fr) *	2000-10-04	2002-12-20	Aventis Pharma Sa	Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite

2004
- 2004-10-14 FR FR0410845A patent/FR2876689B1/fr not_active Expired - Fee Related
2005
- 2005-10-10 HR HR20120168T patent/HRP20120168T1/hr unknown
- 2005-10-10 RS RS20120060A patent/RS52132B/sr unknown
- 2005-10-10 WO PCT/FR2005/002489 patent/WO2006040464A1/fr not_active Ceased
- 2005-10-10 AU AU2005293453A patent/AU2005293453A1/en not_active Withdrawn
- 2005-10-10 MX MX2007004483A patent/MX2007004483A/es active IP Right Grant
- 2005-10-10 BR BRPI0516526-1A patent/BRPI0516526A/pt not_active IP Right Cessation
- 2005-10-10 PL PL05809316T patent/PL1802571T3/pl unknown
- 2005-10-10 DK DK05809316.2T patent/DK1802571T3/da active
- 2005-10-10 SI SI200531476T patent/SI1802571T1/sl unknown
- 2005-10-10 CA CA002581781A patent/CA2581781A1/fr not_active Abandoned
- 2005-10-10 JP JP2007536213A patent/JP4971986B2/ja not_active Expired - Fee Related
- 2005-10-10 KR KR1020077008412A patent/KR20070063540A/ko not_active Withdrawn
- 2005-10-10 ME MEP-2012-19A patent/ME01297B/me unknown
- 2005-10-10 ES ES05809316T patent/ES2378181T3/es not_active Expired - Lifetime
- 2005-10-10 PT PT05809316T patent/PT1802571E/pt unknown
- 2005-10-10 SG SG200805168-2A patent/SG144921A1/en unknown
- 2005-10-10 SG SG200805167-4A patent/SG144920A1/en unknown
- 2005-10-10 EP EP05809316A patent/EP1802571B1/de not_active Expired - Lifetime
- 2005-10-10 AT AT05809316T patent/ATE534624T1/de active
- 2005-10-10 CN CNA2005800350930A patent/CN101039903A/zh active Pending
- 2005-10-10 ZA ZA200703011A patent/ZA200703011B/xx unknown
- 2005-10-10 EA EA200700842A patent/EA012523B1/ru not_active IP Right Cessation
- 2005-10-10 EA EA200801990A patent/EA200801990A1/ru unknown
- 2005-10-13 TW TW094135609A patent/TW200626542A/zh unknown
- 2005-10-13 AR ARP050104295A patent/AR051389A1/es unknown
- 2005-10-14 UY UY29165A patent/UY29165A1/es unknown
2007
- 2007-03-21 CR CR9008A patent/CR9008A/es not_active Application Discontinuation
- 2007-03-28 IL IL182277A patent/IL182277A0/en unknown
- 2007-03-28 US US11/692,462 patent/US7429668B2/en not_active Expired - Lifetime
- 2007-03-28 TN TNP2007000115A patent/TNSN07115A1/fr unknown
- 2007-05-04 MA MA29868A patent/MA29005B1/fr unknown
- 2007-05-11 NO NO20072431A patent/NO20072431L/no not_active Application Discontinuation
2008
- 2008-08-20 US US12/194,644 patent/US7652154B2/en not_active Expired - Lifetime
2009
- 2009-12-11 US US12/635,965 patent/US8071788B2/en not_active Expired - Lifetime
2012
- 2012-02-23 CY CY20121100184T patent/CY1112390T1/el unknown

Also Published As

Publication number	Publication date
US7652154B2 (en)	2010-01-26
JP2008516931A (ja)	2008-05-22
KR20070063540A (ko)	2007-06-19
FR2876689B1 (fr)	2008-02-22
ATE534624T1 (de)	2011-12-15
JP4971986B2 (ja)	2012-07-11
CN101039903A (zh)	2007-09-19
US20080312205A1 (en)	2008-12-18
IL182277A0 (en)	2007-07-24
TNSN07115A1 (fr)	2008-06-02
EA200700842A1 (ru)	2007-08-31
RS52132B (sr)	2012-08-31
MX2007004483A (es)	2007-06-13
SG144920A1 (en)	2008-08-28
CY1112390T1 (el)	2015-12-09
EA012523B1 (ru)	2009-10-30
US7429668B2 (en)	2008-09-30
TW200626542A (en)	2006-08-01
UY29165A1 (es)	2006-05-31
WO2006040464A1 (fr)	2006-04-20
BRPI0516526A (pt)	2008-09-09
ZA200703011B (en)	2009-09-30
NO20072431L (no)	2007-07-04
CA2581781A1 (fr)	2006-04-20
DK1802571T3 (da)	2012-03-12
AU2005293453A1 (en)	2006-04-20
MA29005B1 (fr)	2007-11-01
CR9008A (es)	2007-10-01
EP1802571A1 (de)	2007-07-04
EP1802571B1 (de)	2011-11-23
AR051389A1 (es)	2007-01-10
EA200801990A1 (ru)	2009-06-30
SG144921A1 (en)	2008-08-28
US20100087414A1 (en)	2010-04-08
US8071788B2 (en)	2011-12-06
US20070244084A1 (en)	2007-10-18
ES2378181T3 (es)	2012-04-09
FR2876689A1 (fr)	2006-04-21
SI1802571T1 (sl)	2012-03-30
PT1802571E (pt)	2012-03-05
ME01297B (me)	2013-12-20
PL1802571T3 (pl)	2012-04-30

Publication	Publication Date	Title
AU2014373961B2 (en)	2017-10-26	5-fluoro-4-imino-3-(alkyl/substituted alkyl)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1H)-one and processes for their preparation
Wang et al.	2011	Chloride ion-catalyzed generation of difluorocarbene for efficient preparation of gem-difluorinated cyclopropenes and cyclopropanes
JP6732008B2 (ja)	2020-07-29	シュウ酸アミド系配位子および銅触媒によるハロゲン化アリールのカップリング反応におけるその使用
RU2014128826A (ru)	2016-02-10	Дисоли малоновой кислоты и способ получения малонилдигалогенидов
KR20040030051A (ko)	2004-04-08	아미노피리미딘 화합물의 제조 방법
JP2014525414A (ja)	2014-09-29	ベンゾオキサジノンをアミンと反応させることによるテトラゾール置換アントラニル酸ジアミド誘導体の製造方法
JP6954456B2 (ja)	2021-10-27	スルファミン酸リチウムの製造方法及び新規スルファミン酸リチウム
Jiang et al.	2014	Selective monofluorination of active methylene compounds: the important role of ZnCl 2 in inhibiting overfluorination
HRP20120168T1 (hr)	2012-03-31	Postupak i međuprodukti kod dobivanja derivata n-(1-benzhidrilazetidin-3-il)-n-fenilmetilsulfonamida
EP3812369B1 (de)	2023-04-05	Verfahren zur bromierung von m-diamidverbindungen
JP6400869B1 (ja)	2018-10-03	４，５−ジシアノ−２−（フルオロアルキル）イミダゾールの製造方法
IL185884A (en)	2012-03-29	A method for making converted pyrimidines
US7569703B2 (en)	2009-08-04	Fluorinating agent and method for producing fluorine-containing compound using the same
JP6407645B2 (ja)	2018-10-17	芳香族化合物のパーフルオロアルキル化反応
CA2672256A1 (en)	2008-06-19	Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide
TWI476183B (zh)	2015-03-11	Pyrimidinyl acetonitrile derivatives and their synthesis intermediates
AU2006240772B2 (en)	2011-11-10	Method for producing nicotinic acid derivative or salt thereof
JP6994498B2 (ja)	2022-02-04	３－アミノ－１－（２，６－二置換フェニル）ピラゾール類を調製する方法
JP6183053B2 (ja)	2017-08-23	テトラヒドロピラニルピリミジン化合物の製造方法
JP4738763B2 (ja)	2011-08-03	３，７（９）−ジヒドロ−１ｈ−プリン−２，６−ジチオン化合物の製造方法
CN115724768A (zh)	2023-03-03	一种双酰胺类化合物及其制备方法和应用
JP2006124367A5 (de)	2007-12-20
JP2005206522A (ja)	2005-08-04	２−シアノ−２−（４−テトラヒドロピラニル）酢酸エステルの製法
JP2005097138A (ja)	2005-04-14	スルファモイルオキシ基またはスルフィナモイルオキシ基が置換された芳香族化合物と求核剤との反応による芳香族化合物誘導体の製造方法